Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Suisse (CSUI) EBITDA Margin (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed EBITDA Margin for 8 consecutive years, with 876.36% as the latest value for Q1 2025.

  • On a quarterly basis, EBITDA Margin fell 5236.0% to 876.36% in Q1 2025 year-over-year; TTM through Nov 2025 was 3681.81%, a 265341.0% decrease, with the full-year FY2025 number at 1261.2%, down 41889.0% from a year prior.
  • EBITDA Margin was 876.36% for Q1 2025 at Cannabis Suisse, up from 1216.64% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 524.7% in Q4 2021 to a low of 6199.64% in Q1 2023.
  • A 4-year average of 1399.72% and a median of 851.61% in 2023 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: crashed -139436bps in 2021, then soared 537564bps in 2024.
  • Cannabis Suisse's EBITDA Margin stood at 524.7% in 2021, then dropped by -26bps to 661.88% in 2023, then tumbled by -84bps to 1216.64% in 2024, then rose by 28bps to 876.36% in 2025.
  • Per Business Quant, the three most recent readings for CSUI's EBITDA Margin are 876.36% (Q1 2025), 1216.64% (Q4 2024), and 983.71% (Q3 2024).